Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Gastric Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

October 2019
1. SEO HS, Jung YJ, Kim JH, Lee HH, et al
   The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.
   Am J Clin Oncol. 2019 Oct 29. doi: 10.1097/COC.0000000000000627.
   PubMed     Text format     Abstract available
   
   
   July 2019
2. ZE-LONG Y, Guo-Hui M, Lin Z, Wei-Hong Y, et al
   Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States.
   Am J Clin Oncol. 2019;42:581-587.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. HUANG X, Du H, Aihemaiti M, Liu T, et al
   Laparoscopic-assisted Versus Open D2 Gastrectomy for Advanced Gastric Cancer in Highly Selective Patients: Short-term Surgical and Chemotherapy Outcomes of a Prospective Cohort Study.
   Am J Clin Oncol. 2019 Mar 15. doi: 10.1097/COC.0000000000000534.
   PubMed     Text format     Abstract available
   
   
   February 2019
4. JIN Z, Holubek M, Sukov WR, Sattler CA, et al
   Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.
   Am J Clin Oncol. 2019;42:190-195.
   PubMed     Text format     Abstract available
   
   
   December 2017
5. PALIGA A, Marginean H, Tessier-Cloutier B, Purgina B, et al
   The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
   Am J Clin Oncol. 2017;40:543-551.
   PubMed     Text format     Abstract available
   
   
   September 2017
6. HOSOKAWA A, Ando T, Ogawa K, Ueda A, et al
   Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer.
   Am J Clin Oncol. 2017 Sep 19. doi: 10.1097/COC.0000000000000405.
   PubMed     Text format     Abstract available
   
   
   August 2017
7. LI Q, Li G, Palmer JD, Zhang Z, et al
   Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study.
   Am J Clin Oncol. 2017;40:375-380.
   PubMed     Text format     Abstract available
   
   
   July 2017
8. CALLAHAN AF, White M, Ituarte P, Gagandeep S, et al
   Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease.
   Am J Clin Oncol. 2017 Jul 31. doi: 10.1097/COC.0000000000000392.
   PubMed     Text format     Abstract available
   
   
   April 2017
9. LI J, Yao X, Kortmansky JS, Fischbach NA, et al
   Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.
   Am J Clin Oncol. 2017;40:146-151.
   PubMed     Text format     Abstract available
   
   
   March 2017
10. LIU Y, Zhao G, Xu Y, Zhang T, et al
    Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma.
    Am J Clin Oncol. 2017 Mar 3. doi: 10.1097/COC.0000000000000373.
    PubMed     Text format     Abstract available
    
    
    February 2017
11. LEE YC, Yang PJ, Zhong Y, Clancy TE, et al
    Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry.
    Am J Clin Oncol. 2017;40:35-41.
    PubMed     Text format     Abstract available
    
    
    
12. KOCHI M, Fujii M, Kanamori N, Mihara Y, et al
    Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer.
    Am J Clin Oncol. 2017;40:17-21.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: